- Cambrex (NYSE:CBM +10.1%) Q4 results: Revenues: $156.9M (+21.8%); R&D Expense: $3.5M (+12.9%); SG&A: $16M (+15.9%); Operating Income: $31.1M (+37.6%); Net Income: $17.5M (-38.2%); EPS: $0.53 (-40.4%); Non-GAAP EPS: $1.01 (+57.8%).
- FY2015 results: Revenues: $433.9M (+16.0%); R&D Expense: $12.5M (-4.6%); SG&A: $57.9M (+10.3%); Operating Income: $91M (+74.0%); Net Income: $57.2M (-1.5%); EPS: $1.76 (-4.3%); Non-GAAP EPS: $2.33 (+75.2%); Quick Assets: $44M (-3.3%).
- No guidance given.